Longwood Fund — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Grailgrail.com in 𝕏NASDAQ: GRALMay 2020

GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US

Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)inRichard Klausner(Director)

Co-investorsAmino Capital ARCH Venture Partners Bezos Expeditions Bluebird Ventures Decheng Capital Dentsu Ventures +13 more

Werewolf Therapeuticswerewolftx.com inAug 2020

Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.

BiotechHealthtechMedical DevicesWatertown, US

Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))inDavid Cordo(Executive Officer)Alon Lazarus(Director)

BoardBriggs Morrison(Director)in

Board seatChristoph Westphal· per SEC Form D

Co-investorsDC Investment Partners K2 HealthVentures MPM BioImpact RA Capital Taiho Ventures, LLC UPMC Enterprises

Flexivflexiv.com inDec 2020

Flexiv builds adaptive robots featuring force control, including the Rizon seven-axis robotic arm and Hesper robot controller.

Advanced ManufacturingAI & Machine LearningDeep TechEnergyHardwareRoboticsSilicon Valley, US

Shiquan Wang(Co-Founder and Chief Executive Officer)inXiyang Yeh(Co-Founder and Chief Technology Officer)in

Co-investorsPlug and Play Ventures ZhenFund Gaorong Capital Gaorong Ventures GSR Ventures Invus +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.